View in EDS HTML Full Text PDF Full Text

The efficacy and safety of first-line monotherapies in primary therapy of invasive aspergillosis: a systematic review.

Saved in:
Bibliographic Details
Title: The efficacy and safety of first-line monotherapies in primary therapy of invasive aspergillosis: a systematic review.
Authors: Chen Y; School of Pharmaceutical Sciences, Guizhou University, Guiyang, China.; Department of Pharmacy, Guizhou Provincial People's Hospital, Guiyang, China., Zhao J; School of Pharmaceutical Sciences, Guizhou University, Guiyang, China.; Department of Pharmacy, Guizhou Provincial People's Hospital, Guiyang, China., Wang Y; School of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, China.; Department of Pharmacy, Guizhou Provincial People's Hospital, Guiyang, China., Ge L; Evidence-Based Social Science Research Center, School of Public Health, Lanzhou University, Lanzhou, China.; Department of Social Medicine and Health Management, School of Public Health, Lanzhou University, Lanzhou, China., Kwong JS; Global Health Nursing, Graduate School of Nursing Science, St. Luke's International University, Tokyo, Japan., Lan J; Department of Pharmacy, Guizhou Provincial People's Hospital, Guiyang, China., Zhang R; Department of Pharmacy, Guizhou Provincial People's Hospital, Guiyang, China., Zhao H; Department of Pharmacy, Guizhou Provincial People's Hospital, Guiyang, China., Hu L; Department of Pharmacy, Guizhou Provincial People's Hospital, Guiyang, China., Wang J; Department of Pharmacy, Guizhou Provincial People's Hospital, Guiyang, China., Sun S; Department of Pharmacy, Guizhou Provincial People's Hospital, Guiyang, China., Tan S; Office of Health Insurance Administration, Guizhou Provincial People's Hospital, Guiyang, China., Lin X; School of Public Health, The key Laboratory of Environmental Pollution Monitoringand Disease Control, Ministry of Education, Guizhou Medical University, Guiyang, China., He R; Experimental Cancer Medicine, Department of Laboratory Medicine, Karolinska Institute, Stockholm, Sweden., Zheng W; Experimental Cancer Medicine, Department of Laboratory Medicine, Karolinska Institute, Stockholm, Sweden., Li X; Department of Pharmacy, Hospital of Chengdu Office of People's Government of Tibetan Autonomous Region, Chengdu, China., Zhang J; Department of Pharmacy, Guizhou Provincial People's Hospital, Guiyang, China.
Source: Frontiers in pharmacology [Front Pharmacol] 2025 Jan 15; Vol. 15, pp. 1530999. Date of Electronic Publication: 2025 Jan 15 (Print Publication: 2024).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39881866
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: The efficacy and safety of first-line monotherapies in primary therapy of invasive aspergillosis: a systematic review.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Chen+Y%22">Chen Y</searchLink>; School of Pharmaceutical Sciences, Guizhou University, Guiyang, China.; Department of Pharmacy, Guizhou Provincial People's Hospital, Guiyang, China.<br /><searchLink fieldCode="AU" term="%22Zhao+J%22">Zhao J</searchLink>; School of Pharmaceutical Sciences, Guizhou University, Guiyang, China.; Department of Pharmacy, Guizhou Provincial People's Hospital, Guiyang, China.<br /><searchLink fieldCode="AU" term="%22Wang+Y%22">Wang Y</searchLink>; School of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, China.; Department of Pharmacy, Guizhou Provincial People's Hospital, Guiyang, China.<br /><searchLink fieldCode="AU" term="%22Ge+L%22">Ge L</searchLink>; Evidence-Based Social Science Research Center, School of Public Health, Lanzhou University, Lanzhou, China.; Department of Social Medicine and Health Management, School of Public Health, Lanzhou University, Lanzhou, China.<br /><searchLink fieldCode="AU" term="%22Kwong+JS%22">Kwong JS</searchLink>; Global Health Nursing, Graduate School of Nursing Science, St. Luke's International University, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Lan+J%22">Lan J</searchLink>; Department of Pharmacy, Guizhou Provincial People's Hospital, Guiyang, China.<br /><searchLink fieldCode="AU" term="%22Zhang+R%22">Zhang R</searchLink>; Department of Pharmacy, Guizhou Provincial People's Hospital, Guiyang, China.<br /><searchLink fieldCode="AU" term="%22Zhao+H%22">Zhao H</searchLink>; Department of Pharmacy, Guizhou Provincial People's Hospital, Guiyang, China.<br /><searchLink fieldCode="AU" term="%22Hu+L%22">Hu L</searchLink>; Department of Pharmacy, Guizhou Provincial People's Hospital, Guiyang, China.<br /><searchLink fieldCode="AU" term="%22Wang+J%22">Wang J</searchLink>; Department of Pharmacy, Guizhou Provincial People's Hospital, Guiyang, China.<br /><searchLink fieldCode="AU" term="%22Sun+S%22">Sun S</searchLink>; Department of Pharmacy, Guizhou Provincial People's Hospital, Guiyang, China.<br /><searchLink fieldCode="AU" term="%22Tan+S%22">Tan S</searchLink>; Office of Health Insurance Administration, Guizhou Provincial People's Hospital, Guiyang, China.<br /><searchLink fieldCode="AU" term="%22Lin+X%22">Lin X</searchLink>; School of Public Health, The key Laboratory of Environmental Pollution Monitoringand Disease Control, Ministry of Education, Guizhou Medical University, Guiyang, China.<br /><searchLink fieldCode="AU" term="%22He+R%22">He R</searchLink>; Experimental Cancer Medicine, Department of Laboratory Medicine, Karolinska Institute, Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22Zheng+W%22">Zheng W</searchLink>; Experimental Cancer Medicine, Department of Laboratory Medicine, Karolinska Institute, Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22Li+X%22">Li X</searchLink>; Department of Pharmacy, Hospital of Chengdu Office of People's Government of Tibetan Autonomous Region, Chengdu, China.<br /><searchLink fieldCode="AU" term="%22Zhang+J%22">Zhang J</searchLink>; Department of Pharmacy, Guizhou Provincial People's Hospital, Guiyang, China.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101548923%22">Frontiers in pharmacology</searchLink> [Front Pharmacol] 2025 Jan 15; Vol. 15, pp. 1530999. <i>Date of Electronic Publication: </i>2025 Jan 15 (<i>Print Publication: </i>2024).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Media]%22">Frontiers Media] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101548923 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1663-9812 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216639812%22">16639812 </searchLink><i>NLM ISO Abbreviation: </i>Front Pharmacol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39881866
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fphar.2024.1530999
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1530999
    Titles:
      – TitleFull: The efficacy and safety of first-line monotherapies in primary therapy of invasive aspergillosis: a systematic review.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Chen Y
      – PersonEntity:
          Name:
            NameFull: Zhao J
      – PersonEntity:
          Name:
            NameFull: Wang Y
      – PersonEntity:
          Name:
            NameFull: Ge L
      – PersonEntity:
          Name:
            NameFull: Kwong JS
      – PersonEntity:
          Name:
            NameFull: Lan J
      – PersonEntity:
          Name:
            NameFull: Zhang R
      – PersonEntity:
          Name:
            NameFull: Zhao H
      – PersonEntity:
          Name:
            NameFull: Hu L
      – PersonEntity:
          Name:
            NameFull: Wang J
      – PersonEntity:
          Name:
            NameFull: Sun S
      – PersonEntity:
          Name:
            NameFull: Tan S
      – PersonEntity:
          Name:
            NameFull: Lin X
      – PersonEntity:
          Name:
            NameFull: He R
      – PersonEntity:
          Name:
            NameFull: Zheng W
      – PersonEntity:
          Name:
            NameFull: Li X
      – PersonEntity:
          Name:
            NameFull: Zhang J
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 15
              M: 01
              Text: 2025 Jan 15
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 1663-9812
          Numbering:
            – Type: volume
              Value: 15
          Titles:
            – TitleFull: Frontiers in pharmacology
              Type: main
ResultId 1